iNKT cell-based immunotherapy (Capital medical University)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameiNKT cell-based immunotherapy (Capital medical University)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy
Mechanisms of ActionImmunomodulatorsNatural killer cells modulators
TargetsUpdating
Therapy Area/IndicationsCholangiocarcinoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaClinical
Originator CompaniesBeijing Institute Of Liver Diseases
China Registration ClassN/A

Develop Information

Active CompaniesBeijing Institute Of Liver Diseases
Inactive CompaniesN/A
Active IndicationsCholangiocarcinoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A